JP2025506335A5 - - Google Patents

Info

Publication number
JP2025506335A5
JP2025506335A5 JP2024541088A JP2024541088A JP2025506335A5 JP 2025506335 A5 JP2025506335 A5 JP 2025506335A5 JP 2024541088 A JP2024541088 A JP 2024541088A JP 2024541088 A JP2024541088 A JP 2024541088A JP 2025506335 A5 JP2025506335 A5 JP 2025506335A5
Authority
JP
Japan
Prior art keywords
oral
extract
metabolite
oral preparation
salicylic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024541088A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025506335A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2023/054364 external-priority patent/WO2023161247A1/en
Publication of JP2025506335A publication Critical patent/JP2025506335A/ja
Publication of JP2025506335A5 publication Critical patent/JP2025506335A5/ja
Pending legal-status Critical Current

Links

JP2024541088A 2022-02-22 2023-02-22 サリチル酸組成物およびその使用 Pending JP2025506335A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP22158048 2022-02-22
EP22158048.3 2022-02-22
PCT/EP2023/054364 WO2023161247A1 (en) 2022-02-22 2023-02-22 Salicylic acid compositions and uses thereof

Publications (2)

Publication Number Publication Date
JP2025506335A JP2025506335A (ja) 2025-03-11
JP2025506335A5 true JP2025506335A5 (https=) 2026-02-17

Family

ID=80447273

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024541088A Pending JP2025506335A (ja) 2022-02-22 2023-02-22 サリチル酸組成物およびその使用

Country Status (8)

Country Link
US (1) US20250152609A1 (https=)
EP (1) EP4482580A1 (https=)
JP (1) JP2025506335A (https=)
CN (1) CN118871117A (https=)
AU (1) AU2023224336A1 (https=)
CA (1) CA3261158A1 (https=)
MX (1) MX2024009823A (https=)
WO (1) WO2023161247A1 (https=)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11123356B2 (en) * 2017-03-09 2021-09-21 Epilobium, Inc. Methods of use for oenothein A and B from Epilobium species
US11400102B2 (en) * 2019-05-23 2022-08-02 Washington University Treatment for bacterial infections with salicylic acid analogs

Similar Documents

Publication Publication Date Title
JP2025142338A5 (https=)
JP2007506775A5 (https=)
JP2931409B2 (ja) パラセタモール及びドンペリドンのフィルムコーティング錠
RU2602865C2 (ru) Твердые фармацевтические композиции, содержащие ингибитор интегразы
WO2002096406A1 (en) Medicinal compositions
US20110160264A1 (en) Orally administrable film dosage forms containing ondansetron
EP3360547B1 (en) Bactericidal pharmaceutical composition comprising ibuprofen
JP2008512363A (ja) 経粘膜投与製剤の吸収を高める方法
ES2197087T3 (es) Tabletas tragables con alto contenido de n-acetilcisteina.
JP2025126303A (ja) 錠剤、その製造方法、および医薬品
WO2005013971A1 (en) Pharmaceutical compositions comprising ascorbic acid for the treatment of fungal superfinfections and fungal recurrences
JP2025506335A5 (https=)
WO2008038423A1 (fr) Composition antiphlogistique et analgésique pour une utilisation orale
KR101633292B1 (ko) 용법이 개선된 엔테카비어를 함유하는 약학적 조성물
AU2003217704A1 (en) Diphenhydramine tannate compositions and methods of use
TW200948398A (en) Vancomycin hydrochloride tablet
EP3518935A1 (en) Therapeutic compositions for treatment of human immunodeficiency virus
JP2006528160A (ja) 抗血栓性化合物の口腔分散性医薬組成物
EP4313155A1 (fr) Formulation par voie orale d'ivermectine et utilisations
RU2446802C2 (ru) Противовирусное средство в таблетках и способ его получения
JP7667528B2 (ja) 医薬組成物
WO2024058240A1 (ja) 感冒症状軽減剤
JP2009507850A5 (https=)
WO2025100462A1 (ja) ブロムヘキシンを含む固形組成物
JP2026044494A (ja) 固形組成物及びその製造方法